2013-02-15 16:07:34 - New Healthcare market report from Espicom Business Intelligence: "Physician-based Point of Care Diagnostics: Products, Players and Outlook to 2017"
The market for Point-of-Care (POC) diagnostic products used in the physician's surgery was worth approximately US$1.7 billion in 2011 with sectors such as cholesterol testing and tumour markers making the best continued growth in the year. All sectors will see sustained growth over the medium term, with the total addressable market for products that can be potentially used in a physician's office forging ahead to be valued at over US$6.1 billion by 2017.
In the physician's office, POC diagnostics can play a key role in the diagnosis and ongoing monitoring of acute and chronic illnesses, the detection of some types of cancer, the monitoring of patients on anticoagulation drugs, and for general blood and urine testing. It can also play an
important role in enabling preventative medicine, which is intended to help curb the increasing incidence of chronic conditions such as diabetes and cardiovascular disease through early detection and identifying patients with risk factors that mean they are likely to develop such conditions in the future.
Full Report Details at
- www.fastmr.com/prod/538091_physicianbased_point_of_care_diagnost ..
The benefits for clinicians, patients and health payers are clear. Physician-based testing provides rapid POC diagnosis and faster medical intervention. Healthcare providers are looking for new ways of improving patient outcomes, which in turn reduces the need for more expensive patient care, medications and hospital stays, as well as reducing costs and managing a larger number of patients without increasing staffing levels or numbers of hospital beds.
There are several key challenges in the market. Currently, many physicians’ offices do not have budgets for in-house diagnostic testing and healthcare funding needs to change in order to provide incentives for doctors to use the products. For this to happen, healthcare providers need evidence that POC diagnostics provide benefits in terms of clinical-usefulness, convenience and cost in order to adopt them. In addition, concerns have also been raised about the accuracy of some POC tests used to diagnose conditions such as influenza. For infectious disease testing, the ongoing development of POC PCR and DNA-based systems is expected to improve on currently-available products. These devices could represent a significant market opportunity for manufacturers, should they be able to reduce the testing time and price point of the products to something suitable for and attractive to physicians.
This new January 2013 report delivers a complete analysis
This new 178-page highly-detailed report Physician-based Point-of-Care Diagnostics: Products, Players and Outlook to 2017 provides executives with a complete understanding of the issues which are shaping the market and how they will affect its commercial and clinical development. This is Volume 3 of a 4-Volume study of the whole POC IVD sector to be published late 2012/early 2013.
Partial Table of Contents:
Physician’s Office POC Testing
The Role of POC Testing in a Physician’s Office
Regulatory and Reimbursement Environment
CURRENT MARKET DYNAMICS
Fig.1: POC Diagnostics in Relation to the IVD Market, 2011
Fig.2: Percentage of POC Diagnostics Market by Product, 2011
Fig.3: Professional POC Diagnostics Market by Region, 2011
Physician’s Office POC Testing Market
Addressable Markets for Physician’s Office POC Testing, 2007-2011 (US$ million)
Fig.4: Addressable Markets for Physician’s Office POC Testing, 2011
Fig.5: Physician’s Office POC Testing Market, 2011
GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
POC Diagnostics and the Economy
The Burden of Chronic Disease and Preventative Medicine
Clinical Utility and Accuracy
POC Diagnostics as a Disruptive Technology
Summary: Market Drivers, Restraints and Opportunities
Market Leaders for Physician’s Office POC Testing Products
Select POC Diagnostics Companies’ Sales, 2007-2011 (US$ million)
Merger and Acquisition Activity
Key POC Diagnostics Mergers and Acquisitions, 2008-2011
FUTURE MARKET PROSPECTS
Addressable Markets for Physician’s Office POC Testing, 2011-2017E (US$ million)
Growth in the Addressable Markets for Physician’s Office POC Testing, 2008-2017E (%)
Physician’s Office POC Testing Market, 2011-2012E (US$ million)
Fig.6: Physician’s Office POC Testing Market, 2012(E)
PHYSICIAN’S OFFICE POC PRODUCTS AND TECHNOLOGIES
POC HBA1C TESTING
Diabetes Prevalence and Burden to the Healthcare System
Fig.7: Diabetes Prevalence by Geographic Region, 2011-2030
Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million)
Diabetes Management and the Role of HbA1c Testing
POC HbA1c Testing Market
Fig.8: Global POC HbA1c Testing Market, 2007-2017E (US$ million)
POC HbA1c Products
ApexBio’s A1C Express
Alere/Axis-Shield’s Afinion HbA1c and NycoCard HbA1c Tests
Bayer’s A1CNow Products
Bio-Rad’s in2it A1C Analyser
DiaSys Diagnostic Systems’ InnovaStar
Ceragem Medisys’ HbA1c Analysers
EKF Diagnostics’ Quo-Lab, Quo-Test and Biosen HbA1c Analysers
Infopia’s Easy/Clover A1c
Siemens’ DCA Vantage Analyser
Full Table of Contents is available at:
About Espicom Business Intelligence
Espicom Business Intelligence is a highly-regarded and established provider of business intelligence services. Founded in 1982 as MDIS Publications Ltd, the company changed its name to Espicom in 1992. Initially a publisher in a wide range of industries such as power generation and telecommunications, they now focus on the global pharmaceutical and medical device sectors. View more research from Espicom Business Intelligence at www.fastmr.com/catalog/publishers.aspx?pubid=1025
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.